Advertisement

Journal of Gastrointestinal Surgery

, Volume 14, Issue 11, pp 1826–1831 | Cite as

Pancreatoduodenectomy for Ductal Adenocarcinoma in the Very Elderly; Is It Safe and Justified?

  • Saboor Khan
  • Guido Sclabas
  • Kaye Reid Lombardo
  • Michael G. Sarr
  • David Nagorney
  • Michael L. Kendrick
  • John H. Donohue
  • Florencia G. Que
  • Michael B. Farnell
2010 SSAT Poster Presentation

Abstract

Background

The outcomes of complex major surgery in the elderly are being scrutinized because of the demands on surgical services by an aging population and the concern whether such endeavors are justified. Pancreatoduodenectomy (PD) for pancreatic adenocarcinoma presents special challenges because of the high morbidity of the procedure, dismal prognosis of the disease, and the increasing incidence of pancreatic cancer with age.

Methods

All patients who underwent PD for pancreatic adenocarcinoma from 1981 to 2007 were analyzed for perioperative outcomes, tumor-related parameters, use of adjuvant therapy, and long-term survival. Specifically those aged ≥80 years were compared with a control group aged ≤80 years. Continuous variables are displayed as median and interquartile range (IQR); log-rank test and Cox’s proportional hazards were used to determine survival and effect of age as an independent marker against other covariates.

Results

Fifty-three patients aged ≥80 years underwent PD. Twenty-six (51%) developed complications, including delayed gastric emptying (nine, 17%), pancreatic leak (six, 11%), and postoperative bleeding (five, 9%). There was one in-hospital death (2%). The hospital stay was 13.5 days (IQR 9–19). Forty-one (79%) patients were discharged home; of the 11 (21%) patients who went to an outside health care facility (pancreatic leak/drains and feeding issues—five, delayed gastric emptying/nutritional—four, no home support—one), one died in a nursing home at 5 months while the other ten patients returned to their previous abode (median 4 weeks). The median disease-free and overall survivals were 11.8 (IQR 7.8–18.4) and 13.5 months (IQR 12–21.3). Compared to the non-octogenarians (n = 567), the older population had more poor risk patients with respect to ASA status (P < 0.0004), stayed longer as in-patients (P < 0.04), were more likely to develop complications (P < 0.001), and were less likely to receive adjuvant therapy (P < 0.0001). There was no difference in long-term disease-free or overall survival (log-rank P < 0.30 and P < 0.14), and age did not appear to be an independent marker of prognosis when analyzed (Cox’s proportional hazards P < 0.26; chi-square, 1.25).

Conclusions

In experienced institutions, PD for ductal adenocarcinoma is a viable option in the ambulatory octogenarian population who are deemed operative candidates for a PD. The trade off is a greater complication rate and the prospect of discharge (one in five) to a chronic care facility. The majority, however, can be discharged home with a reasonable functional status, and those discharged to temporary health care rehabilitation facilities are likely to make a recovery over a few weeks.

Keywords

Pancreatic cancer Pancreatic surgery Pancreatoduodenectomy Operative risks 

References

  1. 1.
    United States Census Bureau. 2008 National Population Projections. http://www.census.gov/population/www/projections/.
  2. 2.
  3. 3.
    Crile G, Jr. The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 1970; 130(6):1049–53.PubMedGoogle Scholar
  4. 4.
    Shapiro TM. Adenocarcinoma of the pancreas: a statistical analysis of biliary bypass vs Whipple resection in good risk patients. Ann Surg 1975; 182(6):715–21.CrossRefPubMedGoogle Scholar
  5. 5.
    Cameron JL, Pitt HA, Yeo CJ, et al. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993; 217(5):430–5; discussion 435–8.Google Scholar
  6. 6.
    Schnelldorfer T, Ware AL, Sarr MG, et al. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 2008; 247(3):456–62.CrossRefPubMedGoogle Scholar
  7. 7.
    DiCarlo V, Balzano G, Zerbi A, Villa E. Pancreatic cancer resection in elderly patients. Br J Surg 1998; 85(5):607–10.CrossRefPubMedGoogle Scholar
  8. 8.
    Fong Y, Blumgart LH, Fortner JG, Brennan MF. Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg 1995; 222(4):426–34; discussion 434–7.Google Scholar
  9. 9.
    Brozzetti S, Mazzoni G, Miccini M, et al. Surgical treatment of pancreatic head carcinoma in elderly patients. Arch Surg 2006; 141(2):137–42.CrossRefPubMedGoogle Scholar
  10. 10.
    Sohn TA, Yeo CJ, Cameron JL, et al. Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg 1998; 2(3):207–16.CrossRefPubMedGoogle Scholar
  11. 11.
    Spencer MP, Sarr MG, Nagorney DM. Radical pancreatectomy for pancreatic cancer in the elderly. Is it safe and justified? Ann Surg 1990; 212(2):140–3.CrossRefPubMedGoogle Scholar
  12. 12.
    Hosking MP, Warner MA, Lobdell CM, et al. Outcomes of surgery in patients 90 years of age and older. Jama 1989; 261(13):1909–15.CrossRefPubMedGoogle Scholar
  13. 13.
    Huang JJ, Yeo CJ, Sohn TA, et al. Quality of life and outcomes after pancreaticoduodenectomy. Ann Surg 2000; 231(6):890–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 2004; 240(2):293–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Hardacre JM, Simo K, McGee MF, et al. Pancreatic resection in octogenarians. J Surg Res 2009; 156(1):129–32.CrossRefPubMedGoogle Scholar
  16. 16.
    Makary MA, Winter JM, Cameron JL, et al. Pancreaticoduodenectomy in the very elderly. J Gastrointest Surg 2006; 10(3):347–56.CrossRefPubMedGoogle Scholar
  17. 17.
    Tani M, Kawai M, Hirono S, et al. A pancreaticoduodenectomy is acceptable for periampullary tumors in the elderly, even in patients over 80 years of age. J Hepatobiliary Pancreat Surg 2009; 16(5):675–80.CrossRefPubMedGoogle Scholar
  18. 18.
    Chen JW, Shyr YM, Su CH, et al. Is pancreaticoduodenectomy justified for septuagenarians and octogenarians? Hepatogastroenterology 2003; 50(53):1661–4.PubMedGoogle Scholar
  19. 19.
    Scurtu R, Bachellier P, Oussoultzoglou E, et al. Outcome after pancreaticoduodenectomy for cancer in elderly patients. J Gastrointest Surg 2006; 10(6):813–22.CrossRefPubMedGoogle Scholar
  20. 20.
    Shaw CM, O'Hanlon DM, McEntee GP. Long-term quality of life following pancreaticoduodenectomy. Hepatogastroenterology 2005; 52(63):927–32.PubMedGoogle Scholar
  21. 21.
    Nieveen van Dijkum EJ, Kuhlmann KF, Terwee CB, et al. Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg 2005; 92(4):471–7.Google Scholar
  22. 22.
    Nguyen TC, Sohn TA, Cameron JL, et al. Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg 2003; 7(1):1–9; discussion 9–11.Google Scholar
  23. 23.
    Schniewind B, Bestmann B, Kurdow R, et al. Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses. Ann Surg Oncol 2006; 13(11):1403–11.CrossRefPubMedGoogle Scholar
  24. 24.
    Lightner AM, Glasgow RE, Jordan TH, et al. Pancreatic resection in the elderly. J Am Coll Surg 2004; 198(5):697–706.CrossRefPubMedGoogle Scholar
  25. 25.
    Finlayson E, Fan Z, Birkmeyer JD. Outcomes in octogenarians undergoing high-risk cancer operation: a national study. J Am Coll Surg 2007; 205(6):729–34.CrossRefPubMedGoogle Scholar
  26. 26.
    Yermilov I, Bentrem D, Sekeris E, et al. Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal. Ann Surg Oncol 2009; 16(3):554–61.CrossRefPubMedGoogle Scholar
  27. 27.
    Lea MS, Stahlgren LH. Is resection appropriate for adenocarcinoma of the pancreas? A cost-benefit analysis. Am J Surg 1987; 154(6):651–4.CrossRefPubMedGoogle Scholar
  28. 28.
    Vickers SM, Kerby JD, Smoot TM, et al. Economics of pancreatoduodenectomy in the elderly. Surgery 1996; 120(4):620–5; discussion 625–6.Google Scholar
  29. 29.
    Topal B, Peeters G, Vandeweyer H, et al. Hospital cost-categories of pancreaticoduodenectomy. Acta Chir Belg 2007; 107(4):373–7.PubMedGoogle Scholar
  30. 30.
    Rosemurgy AS, Bloomston M, Serafini FM, et al. Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality. J Gastrointest Surg 2001; 5(1):21–6.CrossRefPubMedGoogle Scholar
  31. 31.
    Ho V, Aloia T. Hospital volume, surgeon volume, and patient costs for cancer surgery. Med Care 2008; 46(7):718–25.CrossRefPubMedGoogle Scholar
  32. 32.
    Pratt WB, Gangavati A, Agarwal K, et al. Establishing standards of quality for elderly patients undergoing pancreatic resection. Arch Surg 2009; 144(10):950–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138(1):8–13.CrossRefPubMedGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2010

Authors and Affiliations

  • Saboor Khan
    • 1
  • Guido Sclabas
    • 1
  • Kaye Reid Lombardo
    • 1
  • Michael G. Sarr
    • 1
  • David Nagorney
    • 1
  • Michael L. Kendrick
    • 1
  • John H. Donohue
    • 1
  • Florencia G. Que
    • 1
  • Michael B. Farnell
    • 1
    • 2
  1. 1.Department of SurgeryMayo ClinicRochesterUSA
  2. 2.Chair Division of Gastroenterologic and General SurgeryRochesterUSA

Personalised recommendations